Manufacture of pharmaceutical preparations
HP HALDEN PHARMA AS
Revenue 2024
NOK 1.3bn
Operating profit
NOK 76.3m
Equity
NOK 57.8m
Incorporated
2023
Employees
694
Share capital
NOK 7.8m
Roles
Daglig lederSebastian Marcus Heckerodt
Revisor
Styrets lederOtto Prange
StyremedlemDietmar Rohleder
StyremedlemTone Janikke Gummesen Thon
StyremedlemTore Andreas Brevig
StyremedlemSiw-Hege Christiansen
StyremedlemBettina Fuderholz
StyremedlemAnja Semmler
VaramedlemFrank Roger Los
VaramedlemVeslemøy Minge Engh
VaramedlemChristine Louise Thorvik Østensvig
VaramedlemAmru Al Hashimi
VaramedlemVibeke Røstengen-Selldin
Auditor
Auditor at related companies
None of the 1 related companies use the same auditor.
| Company | Auditor | |
|---|---|---|
| HP HALDEN AS | AS REVISION | different |
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| PRANGE PHARMA GMBH | 100.0% | 10000000.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.